全球組織工程皮膚替代品的機會不斷成長

Global Tissue-engineered Skin Substitute Growth Opportunities

出版日期: 2023年06月23日 | 出版商:

Frost & Sullivan | 英文 78 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

突破性技術和激烈競爭推動創新

燒傷、交通事故和其他外傷以及糖尿病和靜脈潰瘍等慢性傷口的增加推動全球人造皮膚（組織工程皮膚替代品）市場的發展。此外，手術損傷、整形手術、整容手術和其他重建手術的增加預計將在預測期內（2023-2027年）推動市場成長。2022年，隨著因 COVID-19 大流行而推遲的皮膚更換手術積壓工作開始清理，市場出現收入大幅成長。

這份 Frost & Sullivan 研究報告分析了全球組織工程皮膚替代品市場，並介紹了最終用戶的市場前景、用途類型的市場前景、治療類型的市場前景、市場參與者的市場佔有率百分比等。它還探討了宏觀經濟因素、最新趨勢、收益和預測、美國監管環境以及下一代組織工程皮膚替代技術和解決方案。研究期限為2022年至2027年，基準年為2022年。

它還確定了切實的市場成長機會，重點關注顛覆性創新、未開發的新市場以及美容旅遊的激增。本研究排除了用於骨再生和修復的骨移植市場以及借助同種異體移植物製成的人造器官市場，例如用於心臟用途的同種異體移植主動脈瓣。

皮膚替代品的新興應用領域，如整形手術、重建手術和術後傷口癒合預計將在預測期內增加。

預計將促進組織工程皮膚替代品市場的成長。合成組織工程皮膚替代品用於各種專業外科用途中的重建和修復目的，包括臉部整形手術、真皮填充和根治治療。其他用途包括整容、隆胸以及其他肢體和背部手術。此外，先進產品的推出，包括細胞和脫細胞皮膚噴霧產品，表明在臨床皮膚病學中用於複雜傷口癒合的先進用途。整形外科醫生也擴大使用皮膚替代品來治療幾種類型的皮膚缺陷，而不會最小化供體部位。

注射劑、微粒劑和噴霧劑等新型皮膚替代品正憑藉創新的製造技術進入組織工程皮膚替代品領域，使皮膚替代品能夠快速發展並加速傷口癒合。顧客還想要更便宜、保存期限更長的產品。這些產品還應該容易獲得，使用無麻煩，並且在使用部位造成近乎零感染。顆粒（粉末）胎盤細胞外基質 (ECM)、噴霧皮膚替代品、3D 生物列印皮膚替代品和富血小板血漿 (PRP) 注射是本研究分析的一些下一代解決方案和技術。

該調查還包括 CMS 於2022年 7月宣布的皮膚替代品政策。該政策呼籲皮膚替代傷口護理管理產品更佳反映臨床醫生如何使用它們，並允許更加一致和透明的產品編碼。生物皮膚替代品以比其他兩種類型更高的採用率和偏好佔據市場主導地位。儘管生物皮膚替代品可治療中度至重度燒傷，但合成皮膚替代品領域預計將比生物皮膚替代品成長更快，這主要是由於生物材料技術不斷進步。合成皮膚替代品可以控制支架成分。

分析範圍
區隔
主要競爭- 細胞皮膚替代品
主要競爭- 細胞皮膚替代品
市場進入者的組織工程皮膚替代品前景
最終用戶對組織工程皮膚替代品的看法
組織工程皮膚替代品的用途前景
成長指標
成長促進因素
生長抑制因素
什麼是組織工程皮膚替代品？
皮膚替代品按來源、成分和耐用性分類
按傷口類型定義組織工程皮膚替代品
根據傷口類型選擇組織工程皮膚替代品
從傳統傷口管理產品向現代傷口管理產品的轉變
按植皮類型定義組織工程皮膚替代品
按細胞療法類型定義組織工程皮膚替代品
按細胞療法類型定義組織工程皮膚替代品
使用皮膚替代品 - 優點和缺點
預測假設
盈利和預測
按部門分類的盈利預測
按地區分類的收入預測
預測分析
競爭環境

組織工程皮膚替代品的監管狀況 - 美國

Medicare 承保的傷口護理產品
Medicare 不承保的傷口護理產品
傷口治療範圍 - 概述
美國 FDA 對皮膚替代品的監管現狀
皮膚替代品的兌換場景 - 合成替代品
2023年皮膚替代產品有哪些新變化？

市場進入者提供的產品

市場進入者的產品 - 細胞皮膚替代品
市場進入者的產品 - 細胞皮膚替代品
領先的傷口護理公司

下一代組織工程皮膚替代技術和解決方案

傳統及新應用領域
用於傷口和燒傷的顆粒胎盤 ECM 設備 - InnovaMatrix(R) PD by ConvaTec
透過噴射皮膚細胞促進燒傷癒合
3D生物列印皮膚替代品
富血小板血漿（PRP）注射

成長機會宇宙

成長機會1：顛覆性組織工程皮膚替代品創新
成長機會2：不斷發展的美容旅遊
成長機會3：政府對高級傷口癒合的支持和保險償付
成長機會4：瞄準亞太地區
成長機會5：基於感測器的皮膚貼片和電子皮膚

下一步

下一步
為什麼選擇Frost，為什麼是現在？
附件清單
免責聲明

簡介目錄

Product Code: K8FA-54

Breakthrough Technologies and Competitive Intensity Drive Innovation

Rising incidents of burn injuries, road accidents, and other trauma injuries, along with increasing cases of chronic wounds, such as diabetic ulcers and venous ulcers, are boosting the global tissue-engineered skin substitutes (TESS) market. Moreover, the increasing number of surgical injuries, plastic surgeries, cosmetic surgeries, and other reconstructive surgeries is expected to propel market growth during the forecast period (2023-2027). In 2022, the market witnessed a huge revenue spike as the backlog of skin substitute procedures postponed due to the COVID-19 pandemic started to be cleared.

This Frost & Sullivan study analyzes the global TESS market, including market landscape by end users, application types, therapy types, and market share percentage by market participants. It also examines macroeconomic factors, the latest trends, revenue forecasts, the US regulatory landscape, and next-generation TESS technologies and solutions. The study period is from 2022 to 2027, and the base year is 2022.

The study also highlights specific market growth opportunities, with a focus on disruptive innovation, new unaddressed markets, and the growing prevalence of cosmetic tourism. It excludes the bone grafts market for bone regeneration and repair and the market for artificial organs created with the help of allografts, such as allograft aortic valves in cardiac applications.

New application areas for skin substitutes, including plastic surgeries, reconstructive surgeries, and post-surgical wound healing, are expec

ted to increase during the forecast period and boost TESS market growth. A wide range of specialized surgical applications, such as facial plastic surgery, dermal fillers, and root therapy, use synthetic TESS for reconstructive and repair purposes. Other applications include face-lifts, breast augmentations, and limb or back additions. Moreover, the introduction of advanced products, including cellular and acellular skin spray products, suggests advanced usage in clinical dermatology for complex wound healing. Plastic surgeons are also increasingly using skin substitutes to treat several types of cutaneous defects without minimizing donor sites.

Novel skin substitute types in the form of injectables, particulates, and sprays are entering the TESS space along with innovative manufacturing technologies, enabling the faster development of skin substitutes and resulting in new features that accelerate wound healing. Customers are also demanding less-expensive products that offer longer shelf-life; these products must also be easily available and offer hassle-free application as well as low-to-zero infection at the application site. Particulate (powder form) placental extra-cellular matrix (ECM), spray-on skin substitutes, 3D bioprinted skin substitutes, and platelet-rich plasma (PRP) injections are some next-generation solutions and technologies the study analyzes.

The study also touches upon CMS policies for skin substitute products announced in July 2022, which state that skin substitutes will be called wound care management products to aptly mirror how clinicians use them, enabling more consistent and transparent product coding. Biological skin substitutes dominate the market as the adoption of and preference for these products is higher than the other 2 types. Though biosynthetic skin substitutes treat moderate-to-severe burns, the synthetic segment is expected to witness faster growth than biosynthetic skin substitutes, mainly due to the rising technological advancements in biomaterials. Synthetic skin substitutes demonstrate increased control over scaffold composition.

Strategic Imperatives

Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Tissue-engineered Skin Substitutes Market
Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

Scope of Analysis
Segmentation
Key Competitors-Acellular Skin Substitutes
Key Competitors-Cellular Skin Substitutes
TESS Landscape by Market Participants
TESS Landscape by End Users
TESS Landscape by Applications
Growth Metrics
Growth Drivers
Growth Restraints
Tissue-engineered Skin Substitutes-What are They?
Classification of Skin Substitutes by Origin, Components, and Durability
TESS Definitions by Wound Type
TESS Selection Based on Wound Type
Transition from Traditional to Advanced Wound Management Products
TESS Definitions by Skin Graft Types
TESS Definitions by Acellular Therapy Types
TESS Definitions by Cellular Therapy Types
Skin Substitute Usage-Pros and Cons
Forecast Assumptions
Revenue Forecast
Revenue Forecast by Segment
Revenue Forecast by Region
Forecast Analysis
Competitive Environment

TESS Regulatory Landscape-The United States

Wound Care Supplies Medicare Covers
Wound Care Supplies Medicare Does Not Cover
Wound Care Coverage-An Overview
US FDA Regulatory Status for Skin Substitute Products
Skin Substitute Reimbursement Scenario-Synthetic Substitutes
What's New for Skin Substitute Products in 2023?

Market Participants' Offerings

Market Participants' Products-Acellular Skin Substitutes
Market Participants' Products-Cellular Skin Substitutes
Top Wound Care Companies to Watch

Next-generation TESS Technologies and Solutions

Traditional versus New Application Areas
Particulate Placental ECM Device for Wounds and Burns-ConvaTec's InnovaMatrix® PD
Spraying on Skin Cells to Accelerate Burn Healing
3D Bioprinted Skin Substitutes
Platelet-rich Plasma (PRP) Injections

Growth Opportunity Universe

Growth Opportunity 1: Disruptive TESS Innovation
Growth Opportunity 2: Growing Cosmetic Tourism
Growth Opportunity 3: Government Support and Reimbursements for Advanced Wound Healing
Growth Opportunity 4: Targeting the APAC Region
Growth Opportunity 5: Sensor-based Skin Patches and Electronic Skin